Hollie A Clark1, Kristina E Bowles, Binwei Song, James D Heffelfinger. 1. Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. HClark@cdc.gov
Abstract
OBJECTIVES: The goals of this research were to evaluate perceptions of staff about the effectiveness of methods used by eight community-based organizations (CBOs) to implement human immunodeficiency virus (HIV) counseling and rapid testing in community and outreach settings in seven U.S. cities, and to identify operational challenges. METHODS: A survey was administered to CBO staff to determine their perceptions about the effectiveness of methods used to select testing venues, promote their testing programs, recruit people for testing, provide test results, and link HIV-positive people to health care. Using a Likert scale, respondents rated the effectiveness of methods, their agreement with statements about using mobile testing units (MTUs) and rapid HIV test kits, and operational challenges. RESULTS: Most respondents perceived the methods they used for selecting testing venues, and particularly using recommendations from people receiving testing, to be effective. Most respondents also thought their promotional activities were effective. Respondents believed that using MTUs improved their capacity to reach high-risk individuals, but that MTUs were associated with substantial challenges (e.g., costs to purchase and maintain them). Programmatic challenges included training staff to provide counseling and testing, locating and providing confirmatory test results to people with reactive rapid tests, and sustaining testing programs. CONCLUSIONS: CBO staff thought the methods used to select venues for HIV testing were effective and that using MTUs increased their ability to provide testing to high-risk individuals. However, using MTUs was expensive and posed logistical difficulties. CBOs planning to implement similar programs should take these findings into consideration and pay particular attention to training needs and program sustainability.
OBJECTIVES: The goals of this research were to evaluate perceptions of staff about the effectiveness of methods used by eight community-based organizations (CBOs) to implement human immunodeficiency virus (HIV) counseling and rapid testing in community and outreach settings in seven U.S. cities, and to identify operational challenges. METHODS: A survey was administered to CBO staff to determine their perceptions about the effectiveness of methods used to select testing venues, promote their testing programs, recruit people for testing, provide test results, and link HIV-positive people to health care. Using a Likert scale, respondents rated the effectiveness of methods, their agreement with statements about using mobile testing units (MTUs) and rapid HIV test kits, and operational challenges. RESULTS: Most respondents perceived the methods they used for selecting testing venues, and particularly using recommendations from people receiving testing, to be effective. Most respondents also thought their promotional activities were effective. Respondents believed that using MTUs improved their capacity to reach high-risk individuals, but that MTUs were associated with substantial challenges (e.g., costs to purchase and maintain them). Programmatic challenges included training staff to provide counseling and testing, locating and providing confirmatory test results to people with reactive rapid tests, and sustaining testing programs. CONCLUSIONS: CBO staff thought the methods used to select venues for HIV testing were effective and that using MTUs increased their ability to provide testing to high-risk individuals. However, using MTUs was expensive and posed logistical difficulties. CBOs planning to implement similar programs should take these findings into consideration and pay particular attention to training needs and program sustainability.
Authors: J A Kelly; T G Heckman; L Y Stevenson; P N Williams; T Ertl; R B Hays; N R Leonard; L O'Donnell; M A Terry; E D Sogolow; M S Neumann Journal: AIDS Educ Prev Date: 2000
Authors: Thomas S Liang; Emily Erbelding; Claude A Jacob; Howard Wicker; Carol Christmyer; Sterling Brunson; Damaris Richardson; Jonathan M Ellen Journal: AIDS Patient Care STDS Date: 2005-04 Impact factor: 5.078
Authors: Lisa V Smith; Ellen T Rudy; Marjan Javanbakht; Apurva Uniyal; Lina S Sy; Tiffany Horton; Peter R Kerndt Journal: AIDS Patient Care STDS Date: 2006-10 Impact factor: 5.078
Authors: Mara San Antonio-Gaddy; April Richardson-Moore; Gale R Burstein; Daniel R Newman; Bernard M Branson; Guthrie S Birkhead Journal: J Acquir Immune Defic Syndr Date: 2006-12-01 Impact factor: 3.731
Authors: Freya Spielberg; Bernard M Branson; Gary M Goldbaum; David Lockhart; Ann Kurth; Connie L Celum; Anthony Rossini; Cathy W Critchlow; Robert W Wood Journal: J Acquir Immune Defic Syndr Date: 2003-03-01 Impact factor: 3.731
Authors: Ram K Shrestha; Hollie A Clark; Stephanie L Sansom; Binwei Song; Holly Buckendahl; Cindy B Calhoun; Angela B Hutchinson; James D Heffelfinger Journal: Public Health Rep Date: 2008 Nov-Dec Impact factor: 2.792
Authors: James D Heffelfinger; Patrick S Sullivan; Bernard M Branson; Timothy D Mastro; David W Purcell; Sean D Griffiths; Raul A Romaguera; Robert S Janssen Journal: Public Health Rep Date: 2008 Nov-Dec Impact factor: 2.792
Authors: Malcolm V Williams; Kathryn Pitkin Derose; Frances Aunon; David E Kanouse; Laura M Bogart; Beth Ann Griffin; Ann C Haas; Deborah Owens Collins Journal: Public Health Rep Date: 2016-08-22 Impact factor: 2.792
Authors: Amanda D Castel; Manya Magnus; James Peterson; Karishma Anand; Charles Wu; Marsha Martin; Marie Sansone; Nestor Rocha; Titilola Jolaosho; Tiffany West; Shannon Hader; Alan E Greenberg Journal: Public Health Rep Date: 2012 Jul-Aug Impact factor: 2.792
Authors: Kristina E Bowles; Hollie A Clark; Eric Tai; Patrick S Sullivan; Binwei Song; Jenny Tsang; Craig A Dietz; Julita Mir; Azul Mares-DelGrasso; Cindy Calhoun; Daisy Aguirre; Cicily Emerson; James D Heffelfinger Journal: Public Health Rep Date: 2008 Nov-Dec Impact factor: 2.792
Authors: Kevin P Delaney; Jacqueline Rurangirwa; Shelley Facente; Teri Dowling; Mike Janson; Thomas Knoble; Annie Vu; Yunyin W Hu; Peter R Kerndt; Jan King; Susan Scheer Journal: J Acquir Immune Defic Syndr Date: 2016-01-01 Impact factor: 3.731
Authors: Stacey A Rizza; Robin J MacGowan; David W Purcell; Bernard M Branson; Zelalem Temesgen Journal: Mayo Clin Proc Date: 2012-09 Impact factor: 7.616
Authors: Michelle E Henkhaus; Sophia A Hussen; Devon N Brown; Carlos Del Rio; Michelle R Fletcher; Marxavian D Jones; Amulya Marellapudi; Ameeta S Kalokhe Journal: PLoS One Date: 2021-03-11 Impact factor: 3.240